STAT
JULY 25, 2023
Everyone knows that the United States is the only high-income country without universal health insurance. According to the standard narrative, this is the inevitable result of U.S. exceptionalism — our different values, culture, and institutions. Not so. The impetus for universal coverage is as strong in the United States as in any other country.
PharmaVoice
JULY 25, 2023
Loïc Vincent, chief scientific officer at Affini-T, explains the company’s T cell approach and latest moves toward the clinic.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 25, 2023
With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush. Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.
PharmaVoice
JULY 25, 2023
Merck has invested for more than a decade in reducing maternal death rates in the U.S. and globally. Now for the next chapter.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 25, 2023
Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025. The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%. Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm.
Pharma Marketing Network
JULY 25, 2023
In today’s digital world, partnering with a competent and reliable digital marketing agency is crucial for businesses seeking to enhance their online presence, reach their target audience, and achieve their marketing goals. However, with countless agencies available, it can be overwhelming to find the right one that aligns with your business objectives.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Marketing Network
JULY 25, 2023
Ads Manager is a powerful platform that can help pharma companies reach their target audience and achieve their marketing goals. One of the ways to do this is to customize your audience. This means targeting your ads to people who are most likely to be interested in your products or services. Here are some tips for customizing your audience in Ads Manager for the pharma industry: Use demographics: You can target your ads based on demographics, such as age, gender, location, and interests.
STAT
JULY 25, 2023
Much has been made of Jesse Ehrenfeld’s career of firsts. The current president of the American Medical Association, inaugurated in June , has long advocated for safe and equitable care for sexual and gender minorities, leading to an inaugural National Institutes of Health award for his research in the area. The anesthesiologist was the youngest-ever officer of the Massachusetts Medical Society, and this year became the first openly gay president of the AMA.
Drug Patent Watch
JULY 25, 2023
In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the… The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.
STAT
JULY 25, 2023
A hearing began in a South Africa court on Tuesday to determine whether the government overpaid for Covid-19 vaccines, an allegation made by advocacy groups who contend that a lack of transparency may have masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines during the pandemic.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
JULY 25, 2023
Axatilimab, an anti-CSF-1R antibody to treat chronic graft-versus-host disease (GVHD) has, in a pivotal Phase II trial, demonstrated overall response rates (ORR) of 74 percent, 67 percent and 50 percent, within the first six months of treatment. “[It] is the first investigational chronic GVHD treatment to target inflammation and fibrosis through the inhibition of disease associated macrophages,” stated Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals.
STAT
JULY 25, 2023
Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity. In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.
Pharma Times
JULY 25, 2023
The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases - News - PharmaTimes
STAT
JULY 25, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Pharma Marketing Network
JULY 25, 2023
Google Ads is a great way to reach a wider audience for your pharma business. However, if you want to get the most out of your Google Ads campaigns, you need to optimize them for SEO. Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords.
STAT
JULY 25, 2023
Health care is about many things — understanding and treating disease, practicing medicine, developing new drugs, inventing new medical devices. But at its core, it is about one thing only: the patients. A STAT Report released Tuesday, “ Patients speak out: learning about health care first-person ,” brings those voices to readers in a collection of essays originally published as First Opinion columns.
Pharma Marketing Network
JULY 25, 2023
Traditionally, pharmaceutical companies have relied on demographics to target their marketing efforts. This means that they have focused on reaching consumers based on factors such as age, gender, income, and location. While demographics can be a useful starting point, they are not always enough to create effective marketing campaigns. This is because consumers are not just defined by their demographics.
STAT
JULY 25, 2023
The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information. Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.
Pharmaceutical Commerce
JULY 25, 2023
With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.
Outsourcing Pharma
JULY 25, 2023
Adherence specialist AARDEX Group has been announced as a founding member of the CancerX initiative, which aims to bring diverse stakeholders together to drive innovation and improve follow up for cancer patients.
Pharmaceutical Technology
JULY 25, 2023
Boehringer Ingelheim and Eli Lilly have secured approval from the EC for Jardiance to treat adults with chronic kidney disease (CKD).
European Pharmaceutical Review
JULY 25, 2023
A report from Market Research Biz has illustrated that the small molecule active pharmaceutical ingredient (API) market is expected value around $284.7 billion by 2032. This is a rise from $162.8 billion in 2022. A compound annual growth rate (CAGR) growth of 5.9 percent during the forecast period from 2023 to 2032 is predicted. The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses
Pharma Times
JULY 25, 2023
The CB307 study expansion involves the addition of a new pembrolizumab combination cohort - News - PharmaTimes
Outsourcing Pharma
JULY 25, 2023
H.E.L Group (H.E.L), a global developer and manufacturer of laboratory tools, has signed an agreement with the Indian Institute of Technology Kanpur (IIT Kanpur), a prestigious Indian academic institution kickstarting scientific and technological research.
The Pharmacist
JULY 25, 2023
Progress on government commitments to support community pharmacy ‘require improvement’, an expert panel commissioned by the parliamentary Health and Social Care Committee has found. The panel concluded that the government had not met several of the commitments it made in the 2019 Community Pharmacy Contractual Framework (CPCF), including a commitment to review the sector’s funding […] The post Government progress on pharmacy ‘requires improvement’ appeared first on The Pharmacist.
Outsourcing Pharma
JULY 25, 2023
Predictive Oncology is moving its corporate headquarters to its main laboratory facility in Pittsburgh, PA, a global life sciences hub.
Express Pharma
JULY 25, 2023
Ahead of the World IVF Day, Bharat Serums and Vaccines (BSV) has roped in Bureau Veritas (India), as part of the BSV ART Act Readiness Program. This program aims to assess 50+ IVF centres/clinics (in the first six months) and help them implement the requirements of the Assisted Reproductive Technology Regulations, 2021 (the ART Act), driving them towards greater compliance.
Pharmaceutical Commerce
JULY 25, 2023
Choosing the right pharmacy to administer the program involves a number of factors.
World Pharma News
JULY 25, 2023
A surprising finding from USC reveals key details about how cancer cells metastasize and suggests new therapeutic approaches for halting their spread. The research, supported by the National Institutes of Health, centers on a cellular chaperone protein known as GRP78, which helps regulate the folding of other proteins inside cells.
Drug Channels
JULY 25, 2023
Let’s cut through the steamy summer haze with Drug Channels ’ refreshing breeze of questions for you to ponder while on your favorite pink beach: Why does the biggest PBM need a discount card partner? How do copay accumulators affect prescription adherence? Do nonprofit hospitals deserve their tax exemption? Plus, Dr. Glaucomflecken asks: What would happen if UnitedHealthcare hired physicians who practiced evidence-based medicine?
pharmaphorum
JULY 25, 2023
Jardiance cleared in EU for CKD, challenging Forxiga Phil.
FDA Law Blog: Biosimilars
JULY 25, 2023
By John W.M. Claud & Sara W. Koblitz — We need to talk about nitrosamines. Recent industry comments submitted to FDA and new, international efforts against these nefarious, potentially carcinogenic organic compounds have the shifting state of regulation here back in the news. What are nitrosamines? Nitrosamines are chemicals that can form during drug manufacturing, known by their scientific names as N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), and N-Nitroso-N-methyl-4-aminob
pharmaphorum
JULY 25, 2023
From stealth to spotlight: Marketing strategies to begin Mike.
Pharma Marketing Network
JULY 25, 2023
Sponsorships are a powerful tool that businesses can use to amplify healthcare awareness and education. By partnering with healthcare organizations, businesses can reach a wider audience with important health information and help to promote healthy lifestyles. Here are some examples of how sponsorships can be used to amplify healthcare awareness and education: Johnson & Johnson sponsors the Healthy Living Index.
PharmaState Academy
JULY 25, 2023
Join WhatsApp Group Join the WhatsApp group for quick updates. Zoom link & other details sent on your mail and WhatsApp number. Check your email inbox/ spam folder & WhatsApp account.
Expert insights. Personalized for you.
246 
Let's personalize your content